Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ETCompany ParticipantsShane Xie - Investor RelationsJay Kreps ...

Welcome to the Confluent Q4 and fiscal year 2024 earnings conference call. I'm Shane Xie from investor relations, and I'm joined ...

The primary market to be back in action with nine new initial public offerings (IPO) set to open for subscription next week. Apart from new public issues, the market will also witness six new ...

Chandan Healthcare IPO: The initial public offer (IPO) of Chandan Healthcare, which runs diagnostic centres in North India, kicked off for subscription on Monday, February 10 and closed on ...

Apple's board of directors has declared five stock splits since its 1980 initial public offering (IPO). The stock had several 2-for-1 splits between 1987 and 2005 (June 1987, June 2000 ...

IPO content provided by Renaissance Capital LLC, manager of the IPO-focused ETFs (tickers: IPO, IPOs).

They process this input and the output unlocks our devices. Sensors are used to collect information automatically from the environment and use it as input for a computing device. Weather stations ...

Use our IPO calendar to view upcoming IPOs and recent IPOs. Assess prices and public offering value. Keep track of the latest IPO stocks, news and Initial Public Offering (IPO) analysis. Filter ...

Alcoa's vertical integration, aluminum demand, resilience to tariffs, and potential upside make it an attractive investment ...

Prudential Plc is considering an IPO for ICICI Prudential AMC, involving a partial divestment of its shares. The listing, subject to approvals and market conditions, aims to return proceeds to ...

Nuvectis Pharma, Inc. FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative ...

“In this context, the policy process has abdicated its responsibilities, opting instead for short-term acquiescence with business as usual, rather than offering strong, transparent and cogent ...